Skip to main content
. 2022 Jun 9;8(6):e09660. doi: 10.1016/j.heliyon.2022.e09660

Figure 4.

Figure 4

Extracellular inhibition of SARS-CoV-2 Mpro/3CL and ACE2 activities by TBrC. TBrC exhibited the extracellular inhibition of activities of SARS-CoV-2 Mpro/3CL (A) and ACE2 (B) at the indicated concentrations, but T displayed no significant inhibition. The well-known small molecule inhibitors of Mpro/3CL (Ebselen) and ACE2 (MLN-4760) as the positive controls show remarkable suppression of Mpro/3CL (A) and ACE2 (B) activities.